Min Jie Tang
Finanzdirektor/CFO bei SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO., LTD.
Vermögen: 704 925 $ am 30.04.2024
Aktive Positionen von Min Jie Tang
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO., LTD. | Direktor/Vorstandsmitglied | 14.02.2017 | - |
Finanzdirektor/CFO | 09.12.2016 | - | |
Shenzhen New Industries Material of Ophthalmology Co., Ltd.
Shenzhen New Industries Material of Ophthalmology Co., Ltd. Medical SpecialtiesHealth Technology Shenzhen New Industries Material of Ophthalmology Co., Ltd. engages in the technology development of medical products. It focuses on ophthalmic equipment and ophthalmic device. Its products include fundus slice imaging system Regional Health Authority (RHA), emulsification and vitrectomy equipment R-Evolution CR, model 30 eumatonometer, Tetraflex HD—Aspherical accommodating intraocular lens (IOL), segmental bifocal lens, Tetraflex IOL, Softec HDO Equiconvex Bi-aspheric IOL, Softec HD aspheric IOL, Softec I Foldable Posterior Chamber IOL, OASIS iris expander, healaflow, and ophteisbio. The company was founded on April 27, 2006 and is headquartered in Shenzhen, China. | Direktor/Vorstandsmitglied | 01.11.2016 | - |
Shanghai Hengtai Vision Technology Co., Ltd.
Shanghai Hengtai Vision Technology Co., Ltd. Medical/Nursing ServicesHealth Services Part of Shanghai Haohai Biological Technology Co., Ltd., Shanghai Hengtai Vision Technology Co., Ltd. is a brand that provides comprehensive solutions for "vision protection and eye health" for children and teenagers. The company is based in Shanghai, China. Shanghai Hengtai Vision Technology Co. was acquired by Shanghai Haohai Biological Technology Co., Ltd. on April 21, 2021 for $3.85 million. The Chinese company offers personalized myopia correction, vision correction, and children's eyeglass lenses that cater to the eye habits of Asian children and teenagers. The company was founded in 2017, and the CEO is Guan Han Wu. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Min Jie Tang
Ausbildung von Min Jie Tang
Shanghai University | Undergraduate Degree |
Statistik
International
China | 5 |
Operativ
Director/Board Member | 3 |
Director of Finance/CFO | 1 |
Undergraduate Degree | 1 |
Sektoral
Consumer Services | 2 |
Health Technology | 2 |
Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO., LTD. | Distribution Services |
Private Unternehmen | 2 |
---|---|
Shenzhen New Industries Material of Ophthalmology Co., Ltd.
Shenzhen New Industries Material of Ophthalmology Co., Ltd. Medical SpecialtiesHealth Technology Shenzhen New Industries Material of Ophthalmology Co., Ltd. engages in the technology development of medical products. It focuses on ophthalmic equipment and ophthalmic device. Its products include fundus slice imaging system Regional Health Authority (RHA), emulsification and vitrectomy equipment R-Evolution CR, model 30 eumatonometer, Tetraflex HD—Aspherical accommodating intraocular lens (IOL), segmental bifocal lens, Tetraflex IOL, Softec HDO Equiconvex Bi-aspheric IOL, Softec HD aspheric IOL, Softec I Foldable Posterior Chamber IOL, OASIS iris expander, healaflow, and ophteisbio. The company was founded on April 27, 2006 and is headquartered in Shenzhen, China. | Health Technology |
Shanghai Hengtai Vision Technology Co., Ltd.
Shanghai Hengtai Vision Technology Co., Ltd. Medical/Nursing ServicesHealth Services Part of Shanghai Haohai Biological Technology Co., Ltd., Shanghai Hengtai Vision Technology Co., Ltd. is a brand that provides comprehensive solutions for "vision protection and eye health" for children and teenagers. The company is based in Shanghai, China. Shanghai Hengtai Vision Technology Co. was acquired by Shanghai Haohai Biological Technology Co., Ltd. on April 21, 2021 for $3.85 million. The Chinese company offers personalized myopia correction, vision correction, and children's eyeglass lenses that cater to the eye habits of Asian children and teenagers. The company was founded in 2017, and the CEO is Guan Han Wu. | Health Services |
- Börse
- Insiders
- Min Jie Tang
- Erfahrung